Effect of intracoronary injections of sonicated microbubbles on left ventricular contractility

doi:10.1016/0002-9149(87)91006-X

The American Journal of Cardiology

Volume 60, Issue 1, 1 July 1987, Pages 166-171

https://doi.org/10.1016/0002-9149(87)91006-X Get rights and content

Abstract

Despite the recent interest in contrast-enhanced echocardiography as a means of defining myocardial perfusion, the effects of echo contrast agents on left ventricular (LV) contractility in humans remains poorly defined. This is particularly relevant because intracoronary injection of contrast agents used for angiographic visualization of coronary arteries produces significant alterations in LV hemodynamics. The relation of LV end-systolic wall stress (δ_es) to rate-corrected velocity of fiber shortening (Vcfc), a load-independent index of contractility, was studied in 7 patients undergoing elective coronary arteriography. Two-dimensional and targeted M-mode echocardiographic and central aortic pressure tracings were recorded during injections of standard volumes of angiographic (7 to 9 ml of nonsonicated Renografin-76) and echocardiographic (1.5 to 2.0 ml of sonicated Renografin-76) contrast agents into the left main coronary artery. The order in which agents were injected was randomly determined. Myocardial contractility was assessed under control conditions and 5 and 15 seconds after injection. Alterations in contractility relative to control were measured as the change in Vcfc after elimination of afterload (α_es) as a confounding variable. An injection of Renografin-76 adequate for angiographic imaging of coronary artery anatomy resulted in a significant depression of LV contractility (p <0.001) in conjunction with a tendency toward increased afterload (p = 0.12); recovery occurred by 15 seconds after injection. The smaller amounts of sonicated Renografin-76 required to give adequate contrast enhancement of the myocardium did not alter LV contractile state or afterload. Thus, sonicated Renografin-76 is a safe echocardiographic contrast agent without adverse effects on LV contractility and the volume of contrast material injected rather than the presence of microbubbles appears to be the major determinant of altered myocardial mechanics.

References (25)

T. Santoso et al.
Myocardial perfusion imaging in humans by contrast echocardiography using polygelin colloid solution
JACC
(1985)
R.M. Lang et al.
Contrast echocardiography for evaluation of myocardial perfusion: effects of coronary angioplasty
JACC
(1986)
S. Kaul et al.
Contrast echocardiography in acute myocardial ischemia: in vivo determination o f total left ventricular “area of risk”
JACC
(1984)
P.D. Bourdillon et al.
Effects of a new non-ionic and a conventional ionic contrast agent on coronary sinus ionized calcium and left ventricular hemodynamics in dogs
JACC
(1985)
C.B. Higgins
Mechanisms of cardiovascular effects of contrast media: evidence for transient myocardial calcium ion imbalance
JACC
(1985)
G.B. Mancini et al.
Comparative effects of ionic and nonionic contrast materials on indexes of isovolumic contraction and relaxation in humans
Am J Cordial
(1984)
S.D. Colan et al.
The left ventricular end-systolic wall stress-velocity of fiber shortening relation: a load-independent index of myocardial contractility
JACC
(1984)
S.B. Feinstein et al.
Two-dimensional contrast echocardiography. I. In vitro development and quantitative analysis of echo contrast agents
JACC
(1984)
S.B. Feinstein et al.
Microbubble dynamics visualized in the intact capillary circulation
JACC
(1984)
L.D. Gillam et al.
Functional and pathologic effects of multiple echocardiographic contrast injections on the myocardium, brain and kidney
JACC
(1985)

R.M. Lang et al.

Echocardiographic contrast agents: effect of microbubbles and carrier solutions on left ventricular contractility

JACC

(1987)

M. Goldman et al.

Intraoperative cardioplegia contrast echocardiography for assessing myocardial perfusion during heart surgery

JACC

(1984)

Cited by (18)

Interleukin 8 targeted contrast echocardiography is effective to evaluate myocardial ischemia-reperfusion injury in the rabbits
2019, Biomedicine and Pharmacotherapy
Citation Excerpt :
Moreover, IL-8 level increased in patients who undergo cardiopulmonary bypass and PTCA [18,19]. With the development of ultrasound contrast agents and imaging techniques, myocardial blood flow could be measured quantitatively by myocardial contrast echocardiography (MCE) [20–22]. A large European multicenter study showed that SonoVue-enhanced MCE had superior sensitivity but a lower specificity for detection of coronary artery disease (CAD) compared to SPECT [23].
Interleukin 8 (IL-8) is an important pro-inflammatory cytokine that recruits neutrophil to the areas of inflammation and has been implicated in myocardial ischemia reperfusion injury (MIRI). This study aimed to apply IL-8 targeted myocardial contrast echocardiography (MCE) to evaluate MIRI in rabbits. MCE imaging with IL-8 targeted microbubbles (MB_IL-8) and control microbubbles (MB_c) was performed in 40 Japanese white rabbits after brief proximal left anterior descending (LAD) partial occlusion for 30 min and subsequent reperfusion for 30 min, 60 min, 120 min and 180 min. Electrocardiogram and regional wall motion were assessed during occlusion and reperfusion. MCE demonstrated that IL-8 level rapidly increased in reperfused myocardial tissue and reached the peak after 120 min of reperfusion and lasted to 180 min of reperfusion. ELISA showed that the tendency of MCE data to change with reperfusion time was the same as that of IL-8 content. Taken together, these results suggest that targeted MCE with IL-8 antibody provides a new approach to noninvasive evaluation of MIRI using ultrasound imaging techniques.
Principles of Contrast Echocardiography
2019, Essential Echocardiography: A Companion to Braunwald's Heart Disease
Contrast echocardiography is used for a variety of clinical applications including the delineation of endocardial borders to assess wall motion, enhancement of the blood pool to better appreciate intra-cavitary abnormalities such as thrombi and masses, and assessment of myocardial microvascular perfusion. Contrast echocardiography relies on the ultrasound detection of acoustically active nano- or microparticles that undergo cavitation in an ultrasound field. In their most common form, microbubble contrast agents are composed of a gas core containing a high molecular weight, low-solubility gases; and are encapsulated by lipid, albumin, or polymer shells which reduce gas diffusion and lower surface tension. This chapter describes key technical elements of clinical and research contrast echocardiography including: (1) microbubble composition and characteristics, (2) microbubble behavior in the vasculature and their interactions with native cells and plasma proteins, (3) unique acoustic properties of microbubbles and how they can be leveraged to specifically detect contrast signal during clinical ultrasound imaging, and (4) safety of microbubble contrast agents.
Contrast Echocardiography
2007, Current Problems in Cardiology
Citation Excerpt :
To improve the safety profile, reproducibility, and clinical feasibility, attention was turned towards the development of stable microbubbles that are able to pass freely through pulmonary and systemic capillaries that are typically 5 to 7 μm in diameter.8,9 High-energy sonication of dextrose solutions or iodinated radiopaque contrast agents improved the size distribution somewhat but these agents were to unstable for intravenous use and tended to affect hemodynamics.10-13 The advent of encapsulated microbubble contrast agents has solved many of the problems with stability and size optimization.
Myocardial contrast echocardiography (MCE) is a noninvasive imaging technique that relies on the ultrasound detection of microbubble contrast agents. These agents are confined to the intravascular space thereby producing signal enhancement from the blood pool. This review encompasses many of the key concepts regarding the clinical application of MCE. The first section focuses on the composition, safety, and biokinetics of ultrasound contrast agents. Then we discuss new ultrasound imaging methodology that has been developed to enhance detection of contrast agent and to assess perfusion at the tissue level. Next, the clinical applications of contrast ultrasound are reviewed. These include enhancement of the cardiac chambers for better assessment of cardiac function and masses, myocardial perfusion imaging for the detection of coronary artery disease, and the assessment of myocardial viability and microvascular reflow. Finally, we discuss some of the future applications for MCE, which include molecular imaging of disease and drug/gene delivery. The overall aim of the review is to update the clinician on state-of-the-art MCE and how it can be applied in patients with cardiovascular disease.
3D perfusion mapping in post-infarct mice using myocardial contrast echocardiography
2006, Ultrasound in Medicine and Biology
Myocardial contrast echocardiography (MCE) was used to construct three-dimensional maps of perfusion defects in closed-chest mice, with and without myocardial infarction (MI) induced by permanent coronary ligation. Contiguous, short-axis MCE cine images spanning the heart from apex to base were acquired at 1 mm elevations in each mouse. MCE images at each elevation were color-coded to indicate relative perfusion and were compared with postmortem histology. A strong correlation (R > 0.93) in the size of perfused areas was observed between in vivo measurements and the results of conventional ex vivo tissue staining. 3D multislice and 3D surface renderings of perfusion distribution were created and these perfusion maps also matched well with postmortem histology. These methods provide for the noninvasive determination of the total ischemic region placed at risk by coronary occlusion: this is a critical variable in assessing the potential of novel therapeutic agents to reduce MI size in murine models of ischemia/reperfusion injury.
Myocardial contrast echocardiography: Basic principles
2001, Progress in Cardiovascular Diseases
Myocardial contrast echocardiography (MCE) is a new technique that can be used to examine the myocardial microcirculation. It uses gas-filled microbubbles that behave similarly to red blood cells in the microcirculation. This report describes the parts of the coronary microcirculation visualized by MCE. It also describes the types of microbubbles currently available for research. The properties of microbubbles and their interaction with ultrasound are also described as well as different imaging techniques. This information is necessary to understand the basics of MCE. Copyright © 2001 by W.B. Saunders Company
Progress in Cardiovascular Diseases, Vol. 44, No. 1, (July/August) 2001: pp 1-11
Myocardial contrast echocardiography
1997, Current Problems in Cardiology
MCE has evolved from a laboratory tool to a clinical procedure. It would be wrong to consider it merely another tool for imaging of myocardial perfusion. As discussed, it allows physicians to bring physiology and pathophysiology to the bedside, providing a better understanding of the underlying mechanisms of abnormal findings in individual patients. MCE can provide quantitative measurements that can be repeated as often as necessary in a patient. Because of its complexity, large clinical studies are necessary to define the role of MCE in the general clinical milieu. Advances in MCE continue at a very rapid pace, and its potential for the study of endothelial function, site-specific targeting, and local delivery of drugs appears promising. Its role will continue to evolve into the early part of the next century. What we learn of the myocardium can be easily applied to other organ systems accessible to ultrasound. The future of MCE appears very exciting.

View all citing articles on Scopus

^☆: This work was supported in part by grants from the Goldblatt Research Foundation and the Amoco Foundation, Chicago, Illinois.

View full text

Effect of intracoronary injections of sonicated microbubbles on left ventricular contractility☆

Abstract

JACC

JACC

JACC

JACC

JACC

Am J Cordial

JACC

JACC

JACC

JACC

JACC

JACC